Recombinant Periplaneta brunnea Hypertrehalosaemic factor

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but please specify any format requirements when ordering, and we will accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs by default. For dry ice shipping, please contact us in advance; additional charges will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
Hypertrehalosaemic factor; Adipokinetic hormone 1; PerBr-AKH-1; Hypertrehalosaemic neuropeptide
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-8
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Periplaneta brunnea (Brown cockroach)
Target Protein Sequence
QVNFSPNW
Uniprot No.

Target Background

Function
Hypertrehalosaemic factors are neuropeptides that increase the hemolymph trehalose levels. Trehalose is the primary carbohydrate in insect hemolymph.
Protein Families
AKH/HRTH/RPCH family
Subcellular Location
Secreted.

Q&A

What are hypertrehalosaemic factors and how do they function in Periplaneta brunnea?

Hypertrehalosaemic factors are peptide hormones in cockroaches that regulate trehalose concentration in hemolymph. In Periplaneta species, including P. brunnea, these are typically octapeptides released from the corpora cardiaca. These peptides cause an elevation in hemolymph trehalose levels, which serves as the main circulating sugar in most insects. P. brunnea, as a member of the Blattidae family, contains two hypertrehalosaemic octapeptides with properties identical to the MI and MII peptides characterized in the American cockroach (P. americana) . These factors were initially termed "hyperglycaemic" but later renamed "hypertrehalosaemic factors or hormones" to more accurately reflect their specific role in elevating trehalose rather than glucose .

How do hypertrehalosaemic factors in P. brunnea compare to those in other cockroach species?

Hypertrehalosaemic peptides show distinct phylogenetic patterns across cockroach families. Members of the Blattidae family (including P. brunnea, P. americana, P. australasiae, P. fuliginosa, and Blatta orientalis) possess two hypertrehalosaemic octapeptides similar to P. americana's MI and MII peptides . In contrast, members of the Blaberidae and Blattellidae families (such as Nauphoeta cinerea and Blaberus discoidalis) contain one hypertrehalosaemic decapeptide . More primitive Polyphagidae (Polyphaga aegyptiaca) have two unique hypertrehalosaemic factors that differ from MI, MII, and HTH peptides found in other cockroach families . This pattern reflects evolutionary relationships within the cockroach suborder Blattaria.

What experimental approaches are used to identify and characterize native hypertrehalosaemic peptides?

Modern identification and characterization of hypertrehalosaemic peptides employ several sophisticated techniques:

  • High-resolution mass spectrometry coupled with liquid chromatography (LC-MS) for unequivocal identification of peptides from multiple cockroach species

  • MALDI-TOF mass spectrometry for generating peptide hormone fingerprints and comparing peptide profiles across species

  • Bioassays measuring hemolymph trehalose elevation in response to peptide injection, typically in P. americana

  • Comparative sequence analysis for assessing evolutionary relationships

  • Isolation techniques involving extraction from corpora cardiaca followed by chromatographic separation

The bioassay protocol typically involves resting cockroaches for 1 hour before collecting baseline hemolymph samples, injecting test peptides, waiting 90 minutes, and then collecting a second sample to measure trehalose elevation .

What expression systems are most effective for producing recombinant hypertrehalosaemic factors from P. brunnea?

Based on successful approaches with related cockroach peptides, Escherichia coli expression systems offer an effective platform for recombinant production of P. brunnea hypertrehalosaemic factors. For instance, recombinant allergen Per a 10 (rPer a 10) from P. americana was successfully expressed in E. coli and purified in soluble form, yielding approximately 0.75 mg/liter of culture . Similar methodologies could be applied to P. brunnea peptides, with optimization for the specific characteristics of hypertrehalosaemic factors.

Key considerations for expression system selection include:

  • Codon optimization for bacterial expression

  • Selection of appropriate fusion tags to enhance solubility

  • Inclusion of specific protease cleavage sites for tag removal

  • Optimization of induction conditions to maximize yield

What purification and verification methods should be employed for recombinant hypertrehalosaemic factors?

A comprehensive purification and verification strategy should include:

Purification approaches:

  • Initial capture using affinity chromatography if expression constructs include tags

  • Size exclusion chromatography to separate monomers from aggregates

  • Reverse-phase HPLC for final purification and isolation

Analytical verification methods:

  • SDS-PAGE for purity assessment and molecular weight determination

  • Mass spectrometry for accurate mass determination and sequence verification

  • Circular dichroism (CD) spectroscopy for secondary structure analysis

  • Dynamic light scattering (DLS) for homogeneity assessment

  • Amino acid analysis for composition verification

The purified recombinant factor should be subjected to functional bioassays to confirm biological activity, comparing results with synthetic or native peptides as positive controls.

How can researchers address challenges in maintaining proper structure and function of recombinant hypertrehalosaemic peptides?

Several challenges exist in producing functional recombinant peptides:

  • Post-translational modifications: Bacterial expression systems may not reproduce all modifications present in native peptides, potentially affecting activity. Researchers should consider eukaryotic expression systems for complex modifications.

  • Proper folding: Small peptides may form incorrect structures during recombinant expression. Optimization of expression conditions (temperature, induction time) and inclusion of chaperones can improve folding.

  • Aggregation prevention: Using solubility-enhancing tags and optimizing buffer conditions during purification can minimize aggregation.

  • Activity verification: Comprehensive bioassays comparing native and recombinant peptides are essential. For example, in studies with rPer a 10, researchers observed reduced IgE binding compared to native Per a 10, requiring 96 ng versus 34 ng of native protein for 50% inhibition .

What is the standard bioassay protocol for measuring hypertrehalosaemic activity of recombinant factors?

The standardized bioassay for measuring hypertrehalosaemic activity involves:

  • Acclimatizing cockroaches (typically P. americana) at 25 ± 2°C in individual containers with moist cotton wool

  • Allowing cockroaches to rest in darkness for 1 hour prior to initial sampling

  • Collecting 1 μL of hemolymph from the base of a leg using a glass microcapillary

  • Transferring the hemolymph into 100 μL sulfuric acid

  • Injecting 10 μL of the test solution into the abdominal cavity

  • Returning the cockroach to rest for 90 minutes

  • Collecting a second hemolymph sample following the same procedure

  • Measuring trehalose concentration in both samples to determine the magnitude of elevation

Control experiments should include:

  • Positive control: Synthetic Peram-CAH-I (an endogenous octapeptide of P. americana)

  • Negative control: Vehicle solution without peptide

  • Dose-response analysis to determine potency

Expected results for active peptides typically show trehalose elevation in the range of 15-18 μg/μL at 90 minutes post-injection .

How can researchers evaluate cross-species activity of recombinant hypertrehalosaemic factors?

To evaluate cross-species activity, researchers should:

  • Design a comparative bioassay using multiple cockroach species from different families

  • Standardize injection dosages based on body weight or hemolymph volume

  • Measure baseline trehalose levels in each species to account for natural variation

  • Use species-specific positive controls when available

  • Analyze data considering phylogenetic relationships between test species

What methods can detect differences between native and recombinant hypertrehalosaemic factor activity?

To detect and characterize differences between native and recombinant peptides:

  • Comparative dose-response analysis: Determine EC50 values (effective concentration for 50% maximum response) for both native and recombinant peptides. In studies with cockroach allergens, recombinant proteins like rPer a 10 showed reduced activity compared to native counterparts .

  • Receptor binding assays: Compare binding affinity to receptors isolated from target tissues.

  • Time-course studies: Measure the onset, peak, and duration of trehalose elevation to identify kinetic differences.

  • Cross-species testing: Compare activity across multiple cockroach species to identify species-specific differences in recognition.

  • Proteomic analysis: Identify structural differences such as missing post-translational modifications that might explain functional disparities.

Peptide SourceEC50 for Trehalose ElevationResponse DurationCross-reactivity
Native P. brunnea factorsLower concentration requiredTypically longerStrong across Blattidae
Recombinant factorsHigher concentration requiredMay be shorterMay show reduced cross-species activity

How do the molecular structures of P. brunnea hypertrehalosaemic peptides compare with those from other Periplaneta species?

Hypertrehalosaemic peptides from P. brunnea and other Blattidae family members (including other Periplaneta species) are structurally similar octapeptides. While the exact sequences for P. brunnea peptides aren't detailed in the available search results, they are reported to have "identical properties" to the MI and MII peptides from P. americana . This suggests high sequence conservation within the genus.

The comparative analysis of these peptides across species reveals:

  • Conservation of key structural elements responsible for receptor binding and activation

  • Shared post-translational modifications, particularly C-terminal amidation

  • Similarities in physiochemical properties such as hydrophobicity and charge distribution

These structural similarities explain the cross-reactivity observed in bioassays, where peptides from one Periplaneta species can activate receptors in another.

What critical amino acid residues or structural features are essential for the biological activity of hypertrehalosaemic factors?

Structure-activity relationship studies of hypertrehalosaemic peptides have identified several critical features:

  • C-terminal amidation: This post-translational modification is typically essential for receptor recognition and biological activity

  • N-terminal pyroglutamate: In many insect neuropeptides, this modification protects against degradation and influences receptor binding

  • Conserved hydrophobic residues: Particular positions within the peptide sequence maintain a hydrophobic character across species, suggesting importance in receptor interaction

  • Secondary structure elements: Specific folding patterns may be necessary for proper presentation of key residues to receptors

Recombinant expression systems may not reproduce all these features, potentially explaining activity differences between native and recombinant peptides.

How can advanced structural analysis techniques enhance our understanding of hypertrehalosaemic factor mechanisms?

Advanced structural analysis techniques provide critical insights into the molecular mechanisms of hypertrehalosaemic factors:

  • X-ray crystallography: Reveals the three-dimensional structure of peptides, ideally in complex with their receptors

  • NMR spectroscopy: Provides structural information in solution and can capture dynamic conformational changes

  • Molecular dynamics simulations: Models interactions between peptides and receptors to predict binding modes

  • Hydrogen-deuterium exchange mass spectrometry: Identifies regions involved in binding by measuring changes in solvent accessibility

  • Cryo-electron microscopy: Increasingly used for visualizing peptide-receptor complexes at near-atomic resolution

These techniques, when applied to both native and recombinant peptides, can identify structural differences that explain functional variations and guide optimization of recombinant production methods.

How do cockroach hypertrehalosaemic factors relate to adipokinetic hormones found in other insect orders?

Cockroach hypertrehalosaemic factors belong to the adipokinetic hormone (AKH)/red pigment-concentrating hormone (RPCH) family, which regulates energy metabolism across diverse insect orders:

  • Functional homology: While cockroach factors primarily elevate trehalose, related peptides in other insects mobilize lipids (adipokinetic hormones) or glycogen (hypertrehalosemic hormones)

  • Structural conservation: These peptides typically share features including 8-10 amino acid length, N-terminal blocking, and C-terminal amidation

  • Evolutionary relationships: The varied functions reflect adaptive specialization across insect lineages while maintaining core structural elements

Comparative analysis of recombinant peptides from different orders can provide insights into the evolution of metabolic regulation in insects and the diversification of neuropeptide functions.

What insights does phylogenetic analysis of hypertrehalosaemic peptides provide about cockroach evolution?

Phylogenetic analysis of hypertrehalosaemic peptides offers valuable insights into cockroach evolution:

  • Family-specific patterns: The distribution of octapeptides in Blattidae versus decapeptides in Blaberidae and Blattellidae aligns with established phylogenetic relationships

  • Primitive characteristics: The unique hypertrehalosaemic factors in Polyphagidae, considered evolutionarily basal, provide perspective on the ancestral state

  • Molecular clock: Changes in peptide sequence over evolutionary time can serve as markers for divergence timing

These patterns complement genomic and morphological evidence, contributing to our understanding of cockroach phylogeny. The cladograms derived from MALDI-TOF mass spectra of peptide hormones show topologies generally consistent with recent molecular and morphological studies .

How can genomic resources enhance research on hypertrehalosaemic peptides across cockroach species?

Recent advances in cockroach genomics provide powerful tools for hypertrehalosaemic peptide research:

  • Gene identification: The improved genome assembly of P. americana (3.34 Gb with scaffold N50 of 465.51 Kb and 95.4% completeness) facilitates identification of neuropeptide genes

  • Comparative genomics: Analysis across cockroach species can reveal evolutionary patterns in peptide hormone genes

  • Receptor identification: Genomic data enables identification of G protein-coupled receptors that recognize hypertrehalosaemic peptides

  • Regulatory elements: Promoter and enhancer sequences controlling expression of these peptides can be characterized

  • Synthetic biology applications: Genomic information supports design of expression constructs for recombinant production

The genome of P. americana revealed expansions in gene families associated with chemoreception and detoxification , and similar analysis of P. brunnea could provide insights into neuropeptide evolution and function.

How can recombinant hypertrehalosaemic factors be utilized in metabolic research beyond their primary function?

Recombinant hypertrehalosaemic factors offer versatile tools for broader metabolic research:

  • Metabolic pathway elucidation: Using recombinant peptides to probe trehalose synthesis and breakdown pathways

  • Receptor characterization: Identifying and characterizing receptors through binding studies with labeled recombinant peptides

  • Signaling cascade investigation: Tracing intracellular signaling events triggered by receptor activation

  • Comparative physiology: Examining variations in metabolic responses across developmental stages or physiological conditions

  • Cross-talk with other hormonal systems: Investigating interactions with insulin-like peptides and other metabolic regulators

Research can employ recombinant peptides alongside genomic tools to build comprehensive models of energy metabolism regulation in cockroaches.

What approaches can overcome limitations in cross-species activity of recombinant hypertrehalosaemic factors?

Several strategies can address limitations in cross-species activity:

  • Chimeric peptides: Creating hybrid peptides combining regions from multiple species to enhance cross-reactivity

  • Consensus sequence design: Developing peptides based on conserved elements across multiple species

  • Computational modeling: Using structural predictions to design peptides with broader receptor recognition

  • Site-directed mutagenesis: Systematically modifying specific residues to identify those critical for cross-species activity

  • Alternative expression systems: Employing eukaryotic hosts that may better reproduce native post-translational modifications

These approaches are particularly valuable when studying species for which native peptides are difficult to isolate in sufficient quantities.

How might recombinant hypertrehalosaemic factors contribute to applied research in insect physiology and control?

Recombinant hypertrehalosaemic factors have several potential applications:

  • Metabolic disruption strategies: Developing peptide analogs that disrupt normal energy metabolism in pest species

  • Biomarkers for physiological state: Using receptor expression or responsiveness as indicators of nutritional or developmental status

  • Stress response research: Investigating how energy mobilization via these peptides contributes to stress adaptation

  • Comparative ecological studies: Examining how these systems vary across species with different ecological niches

  • Novel target identification: Discovering species-specific features of trehalose metabolism that might be targeted for selective control

The detailed characterization of these systems using recombinant peptides could reveal vulnerabilities specific to pest cockroach species like P. brunnea.

What strategies can address variability in bioassay results when testing recombinant hypertrehalosaemic factors?

To minimize variability in bioassay results:

  • Standardized test subjects: Use cockroaches of uniform age, sex, and nutritional status

  • Controlled environmental conditions: Maintain consistent temperature (25 ± 2°C) and humidity during testing

  • Acclimation period: Implement a standardized resting period (e.g., 1 hour in darkness) before initial sampling

  • Technical replication: Perform multiple measurements of each sample

  • Biological replication: Test sufficient numbers of individuals to account for natural variation

  • Internal controls: Include positive controls (synthetic peptides) with known activity in each experimental batch

  • Sampling technique standardization: Use consistent methods for hemolymph collection and handling

Statistical approaches should include power analysis for sample size determination and appropriate tests (paired t-tests or ANOVA with post-hoc analysis) for data evaluation.

How can researchers optimize expression constructs to improve yield and activity of recombinant hypertrehalosaemic factors?

Optimization strategies for expression constructs include:

  • Codon optimization: Adjusting codon usage to match the expression host, particularly important for bacterial systems

  • Fusion partners: Including solubility-enhancing tags such as SUMO, thioredoxin, or MBP

  • Signal sequences: Adding appropriate secretion signals if targeting expression to periplasm or culture medium

  • Protease sites: Engineering specific protease cleavage sites that allow complete tag removal without affecting the peptide

  • Promoter selection: Choosing promoters that allow tight regulation and high-level expression

  • Vector stability: Selecting plasmid backbones that remain stable during prolonged culture

For small peptides like hypertrehalosaemic factors, expression as part of a larger fusion protein followed by specific cleavage often yields better results than direct expression.

What analytical techniques best detect post-translational modifications in recombinant versus native hypertrehalosaemic factors?

To identify and characterize post-translational modifications:

  • High-resolution mass spectrometry: Provides precise mass measurements that can identify modifications

  • Tandem mass spectrometry (MS/MS): Enables localization of modifications to specific residues

  • Electron transfer dissociation (ETD): Particularly useful for identifying labile modifications

  • Specialized staining techniques: Can detect specific modifications (e.g., Pro-Q Diamond for phosphorylation)

  • Enzymatic deglycosylation: Reveals the presence of glycan modifications

  • Edman degradation: Can identify N-terminal modifications

Modification TypePrimary Detection MethodConfirmation Approach
C-terminal amidationMS/MSEnzymatic detection
N-terminal pyroglutamateMS/MSPyroglutamate aminopeptidase treatment
PhosphorylationMS/MS, Pro-Q Diamond stainingPhosphatase treatment
GlycosylationMS, PAS stainingGlycosidase treatment
Disulfide bondsNon-reducing vs. reducing SDS-PAGEMS with and without reduction

How might integrating genomics and proteomics advance our understanding of hypertrehalosaemic factor diversity across cockroach species?

An integrated genomics and proteomics approach offers powerful insights:

  • Genome mining: Identifying new peptide hormone genes across cockroach species

  • Transcriptomics: Examining expression patterns under different physiological conditions

  • Comparative proteomics: Identifying species-specific post-translational modifications

  • Peptidomics: Comprehensive cataloging of neuropeptides across species

  • Receptor evolution: Tracking co-evolution of peptides and their receptors

Recent advancements in cockroach genomics, exemplified by the improved P. americana genome assembly , provide templates for similar analyses in P. brunnea and other species. This multi-omics approach could reveal previously unrecognized diversity in hypertrehalosaemic factors and their regulation.

What novel expression systems might improve the production of authentic recombinant hypertrehalosaemic factors?

Emerging expression systems with potential advantages include:

  • Insect cell lines: Provide more authentic post-translational modifications

  • Cell-free protein synthesis: Allows rapid production and modification of expression conditions

  • Yeast systems (Pichia pastoris): Combine high yield with eukaryotic processing capabilities

  • Plant-based expression: Offers economical scaling options with eukaryotic processing

  • Synthetic biology approaches: Designer cells with optimized pathways for specific modifications

Each system offers different advantages for particular aspects of peptide production, and the optimal choice depends on research priorities (yield, authenticity, cost, or scalability).

How can structure-based design approaches create improved hypertrehalosaemic factor analogs for research applications?

Structure-based design offers several promising avenues:

  • Receptor-guided optimization: Using receptor structure to design peptides with enhanced binding

  • Stability engineering: Creating analogs resistant to proteolytic degradation

  • Reporter peptides: Developing fluorescently labeled analogs that retain biological activity

  • Cross-linker incorporation: Designing peptides that can covalently bind to receptors

  • Antagonist development: Creating competitive inhibitors of native peptides

These designed analogs could serve as valuable research tools for investigating receptor distribution, signaling mechanisms, and metabolic regulation in cockroaches and potentially other insects.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.